BIODELIVERY SCIENCES INTL IN's ticker is BDSI and the CUSIP is 09060J106. A total of 76 filers reported holding BIODELIVERY SCIENCES INTL IN in Q4 2013. The put-call ratio across all filers is 0.33 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $2,556,000 | -33.1% | 824,400 | -22.1% | 0.01% | -40.0% |
| Q3 2021 | $3,821,000 | +29.5% | 1,058,400 | +28.4% | 0.01% | +25.0% |
| Q2 2021 | $2,950,000 | -9.7% | 824,100 | -1.4% | 0.01% | -11.1% |
| Q1 2021 | $3,268,000 | +21.7% | 835,900 | +30.7% | 0.01% | +28.6% |
| Q4 2020 | $2,686,000 | -34.2% | 639,600 | -41.5% | 0.01% | -41.7% |
| Q3 2020 | $4,080,000 | -19.5% | 1,093,900 | -5.9% | 0.01% | -20.0% |
| Q2 2020 | $5,066,000 | +21.2% | 1,161,900 | +5.4% | 0.02% | -6.2% |
| Q1 2020 | $4,179,000 | -38.3% | 1,102,600 | +2.9% | 0.02% | 0.0% |
| Q4 2019 | $6,770,000 | +222.8% | 1,071,200 | +115.0% | 0.02% | +220.0% |
| Q3 2019 | $2,097,000 | -31.4% | 498,200 | -24.2% | 0.01% | -37.5% |
| Q2 2019 | $3,055,000 | +180.0% | 656,900 | +219.2% | 0.01% | +166.7% |
| Q1 2019 | $1,091,000 | +541.8% | 205,800 | +1359.6% | 0.00% | +200.0% |
| Q2 2014 | $170,000 | +153.7% | 14,100 | +24.8% | 0.00% | 0.0% |
| Q4 2013 | $67,000 | – | 11,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 2,595,855 | $10,929,000 | 10.61% |
| Broadfin Capital, LLC | 4,300,066 | $18,103,000 | 3.35% |
| 1492 Capital Management LLC | 778,483 | $3,277,000 | 3.20% |
| Avoro Capital Advisors LLC | 7,424,867 | $31,259,000 | 1.30% |
| Rubric Capital Management LP | 2,590,288 | $10,905,000 | 1.00% |
| Eversept Partners, LP | 708,020 | $2,980,764 | 0.92% |
| KNOTT DAVID M | 517,507 | $2,179,000 | 0.92% |
| Nantahala Capital Management | 4,846,167 | $20,402,000 | 0.76% |
| Grandeur Peak Global Advisors, LLC | 1,180,075 | $4,968,000 | 0.54% |
| EMERALD ADVISERS, LLC | 2,084,685 | $8,777,000 | 0.41% |